Natesto nasal gel shows promise in testosterone treatment
Trimel Pharmaceuticals, Inc. recently unveiled the Phase III clinic trial results for its new NATESTOTM testosterone nasal gel at the 2015 Endocrine Society Meeting in San Diego. It is the only FDA-approved (May 2014) nasal testosterone replacement therapy and has already produced significantly positive clinical results. The Phase III trial monitored the effectiveness of NATESTOTM in over 300 …
Natesto nasal gel shows promise in testosterone treatment Read More »